Company intelligence / Profile preview

Athena Feminine Technologies

San Mateo, California, United Statesathenaft.com ↗

Ownership: Private
Employees: ~10
Development stage: Commercial

Overview

Athena Feminine Technologies developed the Athena Pelvic Muscle Trainer™, a patented wireless device that uses mild electrical stimulation to strengthen pelvic floor muscles. The device is FDA-cleared and has been shown in a completed Phase 4 clinical trial ("Athena D.U.E.T.S. Trial") to be effective for treating stress, urge, or mixed urinary incontinence in women by strengthening the pelvic floor. The study also evaluated improvements in sexual health.

Therapeutic areas: Women's Health
Modalities: DeviceNon-pharmacological therapyPelvic Floor Electrical Stimulation (PFES)
Industry: Therapeutic Medical Devices

Beyond the preview

Go deeper on Athena Feminine Technologies.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Athena Feminine Technologies.

Explore the full profile